Publicaciones en las que colabora con Pedro Sánchez Rovira (7)

2024

  1. Real-world clinical scenarios during introduction of trastuzumab biosimilar for HER2-positive breast cancer in the European Union

    Future oncology (London, England), Vol. 20, Núm. 13, pp. 821-832

2020

  1. A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study

    Clinical and Translational Oncology, Vol. 22, Núm. 3, pp. 420-428

2014

  1. Darbepoetin alfa administered once every three weeks for the treatment of anemia in elderly patients with non-myeloid tumors receiving chemotherapy

    Tumori, Vol. 100, Núm. 2, pp. 225-231

2013

  1. Cost-effectiveness analysis of adjuvant therapy with trastuzumab for the treatment of early-stage breast cancer

    Pharmacoeconomics - Spanish Research Articles, Vol. 10, Núm. 1, pp. 27-35

2011

  1. Hormone-responsive breast cancer

    Advances in Therapy, Vol. 28, Núm. 12, pp. 1045-1058

2007

  1. Advanced breast cancer: Chemotherapy phase III trials that change a standard

    Anti-Cancer Drugs

  2. Current controversies in the management of early breast cancer

    Clinical and Translational Oncology, Vol. 9, Núm. 6, pp. 375-384